{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:12:18Z","timestamp":1790208738653,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T00:00:00Z","timestamp":1684022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.drup.2023.100975","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T07:13:38Z","timestamp":1684134818000},"page":"100975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2"],"prefix":"10.1016","volume":"69","author":[{"given":"Qing","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.drup.2023.100975_bib1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.celrep.2016.04.029","article-title":"Metabolic symbiosis enables adaptive resistance to anti-angiogenic therapy that is dependent on mTOR signaling","volume":"15","author":"Allen","year":"2016","journal-title":"Cell Rep."},{"issue":"15","key":"10.1016\/j.drup.2023.100975_bib2","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.drup.2023.100975_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/path.4845","article-title":"Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models","volume":"241","author":"Bridgeman","year":"2017","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib4","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.drup.2023.100975_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.14348\/molcells.2020.0126","article-title":"Long noncoding RNA expression profiling reveals upregulation of uroplakin 1A and uroplakin 1A antisense RNA 1 under hypoxic conditions in lung cancer cells","volume":"43","author":"Byun","year":"2020","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1172\/JCI120855","article-title":"Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers","volume":"129","author":"Chappell","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.drup.2023.100975_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","article-title":"Extracellular vesicle-packaged HIF-1alpha-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells","volume":"21","author":"Chen","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.drup.2023.100975_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7721","key":"10.1016\/j.drup.2023.100975_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0466-7","article-title":"Role of glutamine synthetase in angiogenesis beyond glutamine synthesis","volume":"561","author":"Eelen","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.drup.2023.100975_bib11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm.4197","article-title":"Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases","volume":"22","author":"Frentzas","year":"2016","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.drup.2023.100975_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11523-015-0362-0","article-title":"Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents","volume":"10","author":"Garc\u00eda-Alfonso","year":"2015","journal-title":"Target Oncol."},{"issue":"5","key":"10.1016\/j.drup.2023.100975_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ccell.2018.03.020","article-title":"A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment","volume":"33","author":"Griveau","year":"2018","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.drup.2023.100975_bib14","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-019-1122-z","article-title":"Hypoxia induced LUCAT1\/PTBP1 axis modulates cancer cell viability and chemotherapy response","volume":"19","author":"Huan","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2023.100975_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100849","article-title":"New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects","volume":"64","author":"Huang","year":"2022","journal-title":"Drug Resist. Updat."},{"issue":"10","key":"10.1016\/j.drup.2023.100975_bib17","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1074\/jbc.M117.810101","article-title":"Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism","volume":"293","author":"Huang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2023.100975_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104844","article-title":"Target the human alanine\/serine\/cysteine transporter 2(ASCT2): achievement and future for novel cancer therapy","volume":"158","author":"Jiang","year":"2020","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trecan.2016.11.007","article-title":"Angiogenesis and metabolism: entwined for therapy resistance","volume":"3","author":"Jim\u00e9nez-Valerio","year":"2017","journal-title":"Trends Cancer"},{"issue":"1\u20132","key":"10.1016\/j.drup.2023.100975_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cell.2013.01.004","article-title":"SnapShot: selective autophagy","volume":"152","author":"Jin","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.drup.2023.100975_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/auto.7.3.14487","article-title":"Selective autophagy mediated by autophagic adapter proteins","volume":"7","author":"Johansen","year":"2011","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.drup.2023.100975_bib22","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1073\/pnas.1014480108","article-title":"Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma","volume":"108","author":"Keunen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.drup.2023.100975_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10456-019-09698-6","article-title":"Vessel co-option and resistance to anti-angiogenic therapy","volume":"23","author":"Kuczynski","year":"2020","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.drup.2023.100975_bib25","doi-asserted-by":"crossref","first-page":"djw030","DOI":"10.1093\/jnci\/djw030","article-title":"Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma","volume":"108","author":"Kuczynski","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.drup.2023.100975_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41571-019-0181-9","article-title":"Vessel co-option in cancer","volume":"16","author":"Kuczynski","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","article-title":"Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells","volume":"15","author":"Le","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.drup.2023.100975_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.omtn.2022.03.012","article-title":"The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer","volume":"28","author":"Liu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7","key":"10.1016\/j.drup.2023.100975_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41419-020-2713-8","article-title":"Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2023.100975_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2018.07.007","article-title":"The role of ASCT2 in cancer: A review","volume":"837","author":"Liu","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.drup.2023.100975_bib31","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/ijc.31274","article-title":"Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab","volume":"142","author":"Ma","year":"2018","journal-title":"Int J. Cancer"},{"issue":"5","key":"10.1016\/j.drup.2023.100975_bib32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/0008-5472.CAN-19-1532","article-title":"HIF2-induced long noncoding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis","volume":"80","author":"Niu","year":"2020","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.drup.2023.100975_bib33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.celrep.2016.04.028","article-title":"Targeting metabolic symbiosis to overcome resistance to anti-angiogenic therapy","volume":"15","author":"Pisarsky","year":"2016","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/joim.12016","article-title":"Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force","volume":"273","author":"Polet","year":"2013","journal-title":"J. Intern. Med."},{"issue":"19","key":"10.1016\/j.drup.2023.100975_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157399","article-title":"Targeting FAP\u03b1-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models","volume":"132","author":"Qi","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.drup.2023.100975_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s42003-021-02481-8","article-title":"Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases","volume":"4","author":"Rada","year":"2021","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.drup.2023.100975_bib38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/cancers14051318","article-title":"Cancer cells promote phenotypic alterations in hepatocytes at the edge of cancer cell nests to facilitate vessel co-option establishment in colorectal cancer liver metastases","volume":"14","author":"Rada","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10456-019-09691-z","article-title":"Vessel co-option in glioblastoma: emerging insights and opportunities","volume":"23","author":"Seano","year":"2020","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib40","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cmet.2013.11.022","article-title":"Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth","volume":"19","author":"Sun","year":"2014","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","article-title":"Targeting hypoxic tumor microenvironment in pancreatic cancer","volume":"14","author":"Tao","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.drup.2023.100975_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-020-04218-6","article-title":"The role of the glutamine transporter ASCT2 in antineoplastic therapy","volume":"87","author":"Teixeira","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"issue":"11","key":"10.1016\/j.drup.2023.100975_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109253","article-title":"Tumor vessel co-option probed by single-cell analysis","volume":"35","author":"Teuwen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2023.100975_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-981-15-0602-4_25","article-title":"Autophagy and ubiquitin-proteasome system","volume":"1206","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41467-018-08033-9","article-title":"Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.drup.2023.100975_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","article-title":"A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells","volume":"31","author":"Yoo","year":"2020","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.drup.2023.100975_bib49","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.18632\/aging.204078","article-title":"LncRNA CRART16\/miR-122-5p\/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression","volume":"14","author":"Zhang","year":"2022","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-018-0656-7","article-title":"The lncRNA NEAT1 activates Wnt\/beta-catenin signaling and promotes colorectal cancer progression via interacting with DDX5","volume":"11","author":"Zhang","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2023.100975_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-019-09684-y","article-title":"Models and molecular mechanisms of blood vessel co-option by cancer cells","volume":"23","author":"Zhang","year":"2020","journal-title":"Angiogenesis"},{"issue":"9","key":"10.1016\/j.drup.2023.100975_bib52","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41388-020-01638-9","article-title":"A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability","volume":"40","author":"Zhu","year":"2021","journal-title":"Oncogene"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764623000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764623000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:59:12Z","timestamp":1761281952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764623000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":52,"alternative-id":["S1368764623000584"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2023.100975","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2023.100975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100975"}}